These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12424506)

  • 21. The effects of epoprostenol on drug disposition. I: A pilot study of the pharmacokinetics of digoxin with and without epoprostenol in patients with congestive heart failure.
    Carlton LD; Patterson JH; Mattson CN; Schmith VD
    J Clin Pharmacol; 1996 Mar; 36(3):247-56. PubMed ID: 8690819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic interaction of sparfloxacin and digoxin.
    Johnson RD; Dorr MB; Hunt TL; Conway S; Talbot GH
    Clin Ther; 1999 Feb; 21(2):368-79. PubMed ID: 10211539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic and pharmacodynamic drug-drug interaction assessment between pradigastat and digoxin or warfarin.
    Yan JH; Meyers D; Lee Z; Danis K; Neelakantham S; Majumdar T; Rebello S; Sunkara G; Chen J
    J Clin Pharmacol; 2014 Jul; 54(7):800-8. PubMed ID: 24619917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population pharmacokinetics of digoxin in Korean patients.
    Nagaraja NV; Park YJ; Jeon S; Sands CD; Derendorf H
    Int J Clin Pharmacol Ther; 2000 Jun; 38(6):291-7. PubMed ID: 10890577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral bioavailability of digoxin is enhanced by talinolol: evidence for involvement of intestinal P-glycoprotein.
    Westphal K; Weinbrenner A; Giessmann T; Stuhr M; Franke G; Zschiesche M; Oertel R; Terhaag B; Kroemer HK; Siegmund W
    Clin Pharmacol Ther; 2000 Jul; 68(1):6-12. PubMed ID: 10945310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
    Mahgoub AA; El-Medany AH; Abdulatif AS
    Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of ketoconazole on digoxin absorption and disposition in rat.
    Salphati L; Benet LZ
    Pharmacology; 1998 Jun; 56(6):308-13. PubMed ID: 9654217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic accuracy of a hyperbolic model in predicting digoxin concentrations based on glomerular filtration rates.
    González-López J; Tutor JC
    Nefrologia; 2011; 31(5):573-8. PubMed ID: 21959724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of digoxin administered to horses with congestive heart failure.
    Sweeney RW; Reef VB; Reimer JM
    Am J Vet Res; 1993 Jul; 54(7):1108-11. PubMed ID: 8368606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of recombinant interleukin-2 pretreatment on oral and intravenous digoxin pharmacokinetics and P-glycoprotein activity in mice.
    Castagne V; Bonhomme-Faivre L; Urien S; Ben Reguiga M; Soursac M; Gimenez F; Farinotti R
    Drug Metab Dispos; 2004 Feb; 32(2):168-71. PubMed ID: 14744937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Population pharmacokinetics of digoxin in Thai pediatric patients.
    Preechagoon Y; Somsaard P; Petcharattana S
    J Med Assoc Thai; 2009 Oct; 92(10):1324-35. PubMed ID: 19845241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are there different effects of acarbose and voglibose on serum levels of digoxin in a diabetic patient with congestive heart failure?
    Nagai Y; Hayakawa T; Abe T; Nomura G
    Diabetes Care; 2000 Nov; 23(11):1703. PubMed ID: 11092296
    [No Abstract]   [Full Text] [Related]  

  • 33. [Do we use digitalis properly in the management of elderly patients suffering from the signs of chronic heart failure?].
    Erdei F; Vendrey R; Dani G; Kovács E; Márk L; Katona A
    Orv Hetil; 2006 Oct; 147(41):1993-6. PubMed ID: 17120690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsy.
    Carlsson KC; Hoem NO; Glauser T; Vinks AA
    Clin Ther; 2005 May; 27(5):618-26. PubMed ID: 15978311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population analysis for the optimization of digoxin treatment in Japanese paediatric patients.
    Suematsu F; Minemoto M; Yukawa E; Higuchi S
    J Clin Pharm Ther; 1999 Jun; 24(3):203-8. PubMed ID: 10438180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Personalized pharmacotherapy of digoxin].
    Grundmann M; Kacířová I
    Vnitr Lek; 2015 May; 61(5):406-9. PubMed ID: 26075848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of the digoxin-quinidine interaction via mixed-effect modelling.
    Williams PJ; Lane J; Murray W; Mergener MA; Kamigaki M
    Clin Pharmacokinet; 1992 Jan; 22(1):66-74. PubMed ID: 1559308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of intragastrically administered digoxin in rabbits with experimental bile duct obstruction.
    Wójcicki M; Drozdzik M; Sulikowski T; Gawronska-Szklarz B; Wójcicki J; Rózewicka L; Skowron J; Zielinski S; Musial HD; Zakrzewski J
    J Pharm Pharmacol; 1997 Nov; 49(11):1082-5. PubMed ID: 9401942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a sex-based difference in the pharmacokinetics of digoxin.
    Lee LS; Chan LN
    Pharmacotherapy; 2006 Jan; 26(1):44-50. PubMed ID: 16509025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of digoxin for heart failure and atrial fibrillation in elderly patients.
    Cheng JW; Rybak I
    Am J Geriatr Pharmacother; 2010 Oct; 8(5):419-27. PubMed ID: 21335295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.